Development of Orally Bioavailable Peptides Targeting an Intracellular Protein
Time: 9:20 am
day: Conference Day One
Details:
- Validating of a new methodology to create oral drugs beyond the rule of 5 for intracellular tough targets
- Developing LUNA18: from a hit to a clinical KRAS inhibitor
- Discussing computational chemistry and structure-based molecular design for cyclic peptide drug discovery platform development
